author-photo

O. Militano

Columbia University

20

Papers

142

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Stable to Improved Long Term Cardiac and Pulmonary Function in Children, Adolescents, and Young Adults with High Risk Sickle Cell Disease Following Myeloimmunoablative Conditioning and Familial Haploidentical Stem Cell Transplantation

2021
Show All
- Source
- Cite
- Save
Citations (0)
The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia

2019 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (3)
Abstract 3203: Phase I results of mitoxantrone in combination with clofarabine in children with refractory/relapsed acute leukemia

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
A Pilot Study of Mitoxantrone in Combination With Clofarabine (MITCL) in Children, Adolescents and Young Adults (CAYA) With Refractory/Relapsed Acute Leukemia or High Grade Non-Hodgkin Lymphoma

2014 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Iv Busulfan Administered Q12 Vs Q6 Hrs During Conditioning of Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients Has Comparable Pharmacokinetics and Significant Reduction in Nursing/Pharmacist Costs

2011 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (1)
An Age-Dependent Pharmacokinetic Study of Intravenous and Oral Mycophenolate Mofetil in Combination with Tacrolimus for GVHD Prophylaxis in Pediatric Allogeneic Stem Cell Transplantation Recipients

2010 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (53)
Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days In Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Pharmacokinetically Similar to Q6 Hour Dosing in the Pediatric Population

2009 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
229: Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days in Children Undergoing a Reduced-Intensity Conditioning (RIC) Regimen with Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Safe and Well-Tolerated but Results in Significantly Increased Bu Clearance (CL) and Decreased Area Under the Curve (AUC) and Half-Life (t1/2) When Compared to IV Bu Twice-Daily Dosing Pharmacokinetics (PK) in Adults

2008 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
315: Pharmacokinetics (PK) of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients

2007 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (1)
76: Reduced intenity allogeneic stem cell transplantion followed by targeted consolidation immunotherapy with gemtuzumab ozogamicin in children and adolescents with CD33+ acute myeloid leukemia

2007 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (3)